Godrej Industries Board Approves FY26 Results, ₹1,500 Crore NCD Issuance, and Key Corporate Actions
Godrej Industries' board, at its May 15, 2026 meeting, approved audited standalone and consolidated financial results for Q4 and FY26 with an unmodified auditors' conclusion, alongside the re-appointment of Vishal Sharma as ED & CEO (Chemicals) for FY28–FY30, a ₹1,500 Crore NCD issuance, a ₹1,000 Crore investment in Godrej Investment Limited, and scheduled the 38th AGM for August 13, 2026.

*this image is generated using AI for illustrative purposes only.
The Board of Directors of Godrej Industries Limited, at its meeting held on May 15, 2026, approved a series of significant corporate actions, including the audited financial results for the quarter and financial year ended March 31, 2026, the re-appointment of a key executive, a major fundraising initiative, a substantial subsidiary investment, and the scheduling of its upcoming Annual General Meeting. These decisions were taken pursuant to Regulations 30, 33, 51, and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Approval of Audited Financial Results for FY26
Upon the recommendation of the Audit Committee, the board approved the Audited Financial Results (Standalone & Consolidated) as per Indian Accounting Standards (Ind AS) for the quarter and financial year ended March 31, 2026, along with the Statement of Assets and Liabilities as on March 31, 2026, and the Cash Flow Statement for the financial year ended March 31, 2026. The board also took note of the Statutory Auditors' Report on the audited financial results for the same period.
| Parameter: | Details |
|---|---|
| Results Type: | Audited Standalone & Consolidated |
| Accounting Standard: | Indian Accounting Standards (Ind AS) |
| Period Covered: | Quarter and Financial Year ended March 31, 2026 |
| Auditors' Conclusion: | Unmodified |
The Statutory Auditors' Report carries an unmodified conclusion with respect to the audited financial results — both standalone and consolidated — of the Company for the quarter and financial year ended March 31, 2026.
Re-Appointment of Whole Time Director
Upon the recommendation of the Nomination and Remuneration Committee, the board approved the re-appointment of Mr. Vishal Sharma (DIN: 00085416) as Whole Time Director, designated as Executive Director & Chief Executive Officer (Chemicals), for a fresh term commencing April 1, 2027, and ending March 31, 2030. The re-appointment is subject to shareholder approval. Mr. Sharma's current tenure is set to conclude on March 31, 2027.
The key details of the re-appointment are summarised below:
| Parameter: | Details |
|---|---|
| Name: | Mr. Vishal Sharma |
| DIN: | 00085416 |
| Designation: | Executive Director & Chief Executive Officer (Chemicals) |
| Effective Date: | April 1, 2027 |
| Term End Date: | March 31, 2030 |
| Subject To: | Shareholder Approval |
Profile of Mr. Vishal Sharma
Mr. Vishal Sharma joined the Godrej Group in 2023 and brings 30 years of business experience, primarily in the specialty and process chemicals space, serving both industrial and institutional segments. He has operated across five continents in both developed and developing markets, and has led start-up businesses with multiple transformational and scale-up initiatives to his credit. He also serves as Chairperson of Astec LifeSciences Limited.
Prior to joining Godrej, Mr. Sharma spent a decade at Ecolab, leading businesses across Asia Pacific, India, the Middle East, and Africa. He has also held leadership roles at Diversey and began his career with GE. He holds a postgraduate diploma in Management from IMDR Pune and a Bachelor's degree in Engineering from MIT Manipal. The board has disclosed that Mr. Vishal Sharma is not related to any of the Promoters, members of the Promoter Group, or Directors of the Company, and is not debarred from holding the office of Director by any order of SEBI or any other authority.
Fundraising via NCDs and Subsidiary Investment
The board approved two significant financial decisions at the same meeting. First, it approved raising funds through the issuance of Unsecured Non-Convertible Debentures (NCDs) / Bonds / Other Instruments, on a private placement basis, in one or more tranches. Second, it approved a further investment in its wholly-owned subsidiary.
| Decision: | Details |
|---|---|
| NCD / Bond Issuance (Maximum): | ₹1,500 Crore |
| Listing: | Listed and/or Unlisted |
| Placement Basis: | Private Placement |
| Validity Period: | 1 year from date of shareholder approval |
| Subsidiary Investment (Maximum): | ₹1,000 Crore |
| Subsidiary Name: | Godrej Investment Limited |
| Subsidiary Type: | Wholly-Owned Subsidiary |
| Regulatory Reference: | Section 186 of the Companies Act, 2013 |
The Management Committee of the Board of Directors has been authorised to determine the detailed terms and conditions of the NCD / Bond issue, including the issue price and all necessary ancillary steps. Both the NCD issuance and the subsidiary investment are subject to shareholder approval.
Annual General Meeting and Postal Ballot
The board fixed the date of the 38th Annual General Meeting (AGM) of the Company for Thursday, August 13, 2026, to be held through Video Conferencing / Other Audio-Visual Means. The Register of Members and Share Transfer Books will remain closed from Thursday, August 6, 2026, to Thursday, August 13, 2026 (both days inclusive) for the purpose of the AGM.
Separately, the board approved a Postal Ballot Notice dated May 15, 2026, for obtaining shareholder approval for the appointment of Mr. Burjis Godrej (DIN: 08183082) as Director (Non-Executive Non-Independent Director) of the Company, with effect from August 14, 2026. The cut-off date for determining shareholder eligibility for voting on the Postal Ballot has been fixed as Friday, May 15, 2026.
Historical Stock Returns for Godrej Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.13% | +3.57% | +20.87% | +6.05% | -3.93% | +98.23% |
How might Godrej Industries deploy the ₹1,500 crore raised through NCDs, and what impact could this leverage have on its debt-to-equity ratio and credit ratings?
What strategic purpose does the ₹1,000 crore investment in Godrej Investment Limited serve, and could it signal an upcoming acquisition or expansion in a specific sector?
With Mr. Vishal Sharma's re-appointment extending to 2030, what growth targets or transformation milestones is the Chemicals division expected to achieve under his continued leadership?


































